ABCL
Price
$3.61
Change
-$0.13 (-3.48%)
Updated
Jun 27 closing price
Capitalization
1.08B
45 days until earnings call
CRSP
Price
$46.70
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
4.1B
44 days until earnings call
Interact to see
Advertisement

ABCL vs CRSP

Header iconABCL vs CRSP Comparison
Open Charts ABCL vs CRSPBanner chart's image
AbCellera Biologics
Price$3.61
Change-$0.13 (-3.48%)
Volume$6.21M
Capitalization1.08B
CRISPR Therapeutics AG
Price$46.70
Change-$0.00 (-0.00%)
Volume$32.88K
Capitalization4.1B
ABCL vs CRSP Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CRSP commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CRSP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ABCL: $3.61 vs. CRSP: $46.70)
Brand notoriety: ABCL and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 114% vs. CRSP: 1%
Market capitalization -- ABCL: $1.08B vs. CRSP: $4.1B
ABCL [@Biotechnology] is valued at $1.08B. CRSP’s [@Biotechnology] market capitalization is $4.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ABCL and CRSP are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +5.87% price change this week, while CRSP (@Biotechnology) price change was +5.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.1B) has a higher market cap than ABCL($1.08B). ABCL YTD gains are higher at: 23.208 vs. CRSP (20.655). ABCL has higher annual earnings (EBITDA): -211.2M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. ABCL (605M). ABCL has less debt than CRSP: ABCL (67.8M) vs CRSP (219M). CRSP has higher revenues than ABCL: CRSP (35M) vs ABCL (23.1M).
ABCLCRSPABCL / CRSP
Capitalization1.08B4.1B26%
EBITDA-211.2M-455.24M46%
Gain YTD23.20820.655112%
P/E RatioN/AN/A-
Revenue23.1M35M66%
Total Cash605M1.86B33%
Total Debt67.8M219M31%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWZLX20.130.22
+1.10%
Nationwide Loomis All Cap Gr A
TWGGX12.050.09
+0.75%
American Century Focused Global Gr Inv
FSCTX23.71N/A
N/A
Fidelity Advisor Small Cap M
TEQHX12.56N/A
N/A
Nuveen Emerging Markets Eq Idx I
RIERX12.93N/A
N/A
RBC International Equity R6

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-3.48%
CRSP - ABCL
62%
Loosely correlated
+1.69%
RXRX - ABCL
58%
Loosely correlated
-6.85%
ABSI - ABCL
57%
Loosely correlated
-3.32%
NTLA - ABCL
56%
Loosely correlated
-0.52%
BEAM - ABCL
55%
Loosely correlated
-1.98%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.69%
BEAM - CRSP
72%
Closely correlated
-1.98%
RXRX - CRSP
71%
Closely correlated
-6.85%
NTLA - CRSP
65%
Loosely correlated
-0.52%
ALLO - CRSP
62%
Loosely correlated
-1.67%
PRME - CRSP
62%
Loosely correlated
-8.68%
More